LBF20000AM01: Difference between revisions
No edit summary |
No edit summary |
||
| Line 9: | Line 9: | ||
|Common Name=&&N-eicosanoylethanolamine&& | |Common Name=&&N-eicosanoylethanolamine&& | ||
|Source= | |Source= | ||
|Chemical Synthesis=This compound was synthesized from eicosanoylchloride and ethanolamine. [[Reference:Adams_IB:Ryan_W:Singer_M:Thomas_BF:Compton_DR:Razdan_RK:Martin_BR:,J. Pharmacol. Exp. Ther.,1995,273,1172|{{RelationTable/GetFirstAuthor|Reference:Adams_IB:Ryan_W:Singer_M:Thomas_BF:Compton_DR:Razdan_RK:Martin_BR:,J. Pharmacol. Exp. Ther.,1995,273,1172}}]] | |Chemical Synthesis=This compound was synthesized from eicosanoylchloride and ethanolamine. [[Reference:Adams_IB:Ryan_W:Singer_M:Thomas_BF:Compton_DR:Razdan_RK:Martin_BR:,J. Pharmacol. Exp. Ther.,1995,273,1172|{{RelationTable/GetFirstAuthor|Reference:Adams_IB:Ryan_W:Singer_M:Thomas_BF:Compton_DR:Razdan_RK:Martin_BR:,J. Pharmacol. Exp. Ther.,1995,273,1172}}]] | ||
|Metabolism= | |Metabolism= | ||
}} | }} | ||
{{Lipid/Footer}} | {{Lipid/Footer}} | ||
Revision as of 11:55, 25 November 2009
| LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
| IDs and Links | |
|---|---|
| LipidBank | XPR7062 |
| LipidMaps | - |
| CAS | |
| KEGG | {{{KEGG}}} |
| KNApSAcK | {{{KNApSAcK}}} |
| mol | LBF20000AM01 |
| N-eicosanoylethanolamine | |
|---|---|
| |
| Structural Information | |
| N-eicosanoylethanolamine | |
| |
| Formula | C22H45NO2 |
| Exact Mass | 355.345029689 |
| Average Mass | 355.59824000000003 |
| SMILES | C(CCC(=O)NCCO)CCCCCCCCCCCCCCCC |
| Physicochemical Information | |
| This compound was synthesized from eicosanoylchloride and ethanolamine. Adams_IB et al. | |
| Spectral Information | |
| Mass Spectra | |
| UV Spectra | |
| IR Spectra | |
| NMR Spectra | |
| Other Spectra | |
| Chromatograms | |
| Reported Metabolites, References | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
